PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $590,225 | +8.7% | 19,301 | +3.4% | 0.00% | 0.0% |
Q1 2024 | $542,965 | +3.9% | 18,665 | -1.5% | 0.00% | 0.0% |
Q4 2023 | $522,427 | +22.6% | 18,956 | -0.3% | 0.00% | 0.0% |
Q3 2023 | $426,059 | -43.9% | 19,012 | +1.9% | 0.00% | -33.3% |
Q2 2023 | $758,902 | -16.4% | 18,660 | -0.5% | 0.01% | -25.0% |
Q1 2023 | $908,008 | +30.9% | 18,745 | +3.2% | 0.01% | +14.3% |
Q4 2022 | $693,473 | -20.8% | 18,168 | +4.1% | 0.01% | -22.2% |
Q3 2022 | $876,000 | +25.7% | 17,447 | +0.2% | 0.01% | +28.6% |
Q2 2022 | $697,000 | +8.6% | 17,405 | +1.2% | 0.01% | +40.0% |
Q1 2022 | $642,000 | -5.7% | 17,200 | +0.6% | 0.01% | 0.0% |
Q4 2021 | $681,000 | +5.9% | 17,103 | -1.0% | 0.01% | 0.0% |
Q3 2021 | $643,000 | -11.6% | 17,272 | +0.4% | 0.01% | -16.7% |
Q2 2021 | $727,000 | -14.1% | 17,204 | -3.8% | 0.01% | -14.3% |
Q1 2021 | $846,000 | -21.5% | 17,877 | +1.2% | 0.01% | -30.0% |
Q4 2020 | $1,078,000 | +35.1% | 17,671 | +3.5% | 0.01% | +25.0% |
Q3 2020 | $798,000 | +25.7% | 17,074 | +36.4% | 0.01% | -11.1% |
Q2 2020 | $635,000 | +9.3% | 12,520 | -3.9% | 0.01% | -10.0% |
Q1 2020 | $581,000 | – | 13,022 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |